Literature DB >> 15940780

Persistent cryoglobulinemic vasculitis following successful treatment of hepatitis C virus.

James W Levine1, Carmen Gota, Barri J Fessler, Leonard H Calabrese, Sheldon M Cooper.   

Abstract

There is a well established link between type II mixed cryoglobulinemia (MC) and hepatitis C virus (HCV) infection, and HCV is believed to be the cause of cryoprotein formation and tissue deposition. Successful treatment of HCV infection has resulted in resolution of cryoglobulinemia and vasculitis. We describe 4 patients who had persistent MC and vasculitis despite successful eradication of HCV with antiviral therapy.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15940780

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  19 in total

Review 1.  Management of patients with hepatitis C infection and renal disease.

Authors:  Chalermrat Bunchorntavakul; Monthira Maneerattanaporn; Disaya Chavalitdhamrong
Journal:  World J Hepatol       Date:  2015-02-27

Review 2.  Role of hepatitis C virus in B cell lymphoproliferations.

Authors:  Felicia Tucci; Ralf Küppers
Journal:  Virol Sin       Date:  2014-02       Impact factor: 4.327

Review 3.  Cryoglobulinaemic vasculitis: classification and clinical and therapeutic aspects.

Authors:  Gerald S Braun; Sophia Horster; Katrin S Wagner; Stephan Ihrler; Holger Schmid
Journal:  Postgrad Med J       Date:  2007-02       Impact factor: 2.401

4.  Hepatitis C virus (genotype 4)-associated mixed cryoglobulinemia vasculitis: effects of antiviral treatment.

Authors:  Hisham R El Khayat; Yasser M Fouad; Ezzat Ali Ahmad; Hussein El Amin; Faten Ismael; Amal Rizk
Journal:  Hepatol Int       Date:  2011-08-19       Impact factor: 6.047

Review 5.  Hepatitis C virus-induced cryoglobulinemia.

Authors:  Edgar D Charles; Lynn B Dustin
Journal:  Kidney Int       Date:  2009-07-15       Impact factor: 10.612

6.  Management of chronic hepatitis C: consensus guidelines.

Authors:  Morris Sherman; Stephen Shafran; Kelly Burak; Karen Doucette; Winnie Wong; Nigel Girgrah; Eric Yoshida; Eberhard Renner; Philip Wong; Marc Deschênes
Journal:  Can J Gastroenterol       Date:  2007-06       Impact factor: 3.522

Review 7.  Hepatitis C virus-related lymphoproliferative disorders: an overview.

Authors:  Anna-Linda Zignego; Carlo Giannini; Clodoveo Ferri
Journal:  World J Gastroenterol       Date:  2007-05-07       Impact factor: 5.742

8.  Abnormal B-cell activation associated with TALL-1 over-expression and SOCS-1 suppression during chronic hepatitis C virus infection.

Authors:  Jonathan Moorman; Zhi P Dong; Lei Ni; Chunlan Zhang; Thomas Borthwick; Zhi Q Yao
Journal:  Immunology       Date:  2009-10       Impact factor: 7.397

9.  A retrospective analysis of treatment outcomes in patients with hepatitis C related systemic vasculitis receiving intravenous methylprednisolone and cyclophosphamide.

Authors:  Amira A Shahin; Soha M El Desouky; Hania S Zayed
Journal:  Clin Rheumatol       Date:  2010-10-06       Impact factor: 3.650

Review 10.  Hepatitis C virus infection and mixed cryoglobulinemia.

Authors:  Gianfranco Lauletta; Sabino Russi; Vincenza Conteduca; Loredana Sansonno
Journal:  Clin Dev Immunol       Date:  2012-07-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.